Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

As enterprises grapple with ever-evolving data landscapes, the need for reliable, scalable migration solutions is more ...

Several factors can catalyze an oil price recovery and EPS growth for Enterprise Products Partners. Read more about these ...

Shares Core Dividend ETF's strong dividend growth, attractive valuation, and bullish trends make it a standout ETF. Read here ...